TriangleNCT04162873 · OUTCOME
Assessment of the Average Number of Treatment Days Missed During Adjuvant Radiation for Patients on Celecoxib Compared to Placebo.
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- COUNT_OF_PARTICIPANTS
- Unit
- Participants
- Interval / dispersion
- Not reported
- Time frame
- up to 140 days
What was measured
This outcome will report the number of participants who missed treatment days during adjuvant radiation, who did not miss any treatment days during adjuvant radiation, and the number of participants who did not start adjuvant radiation therapy.
Analysis population: One participant on the Celecoxib Arm was not evaluable for this outcome measure.
Groups in this outcome
Celecoxib Arm
Patients received celecoxib PO or via feeding tube BID starting 1 to 7 days prior to surgery and continued until the completion of radiation therapy (up to 6 months in total) in the absence of disease progression or unacceptable toxicity. Celecoxib: Given PO or via feeding tube Quality-of-Life Assessment: Ancillary studies Questionnaire Administration: Ancillary studies
Placebo Arm
Patients received placebo PO or via feeding tube BID starting 1 to 7 days prior to surgery and continued until the completion of radiation therapy (up to 6 months in total) in the absence of disease progression or unacceptable toxicity. Placebo: Given PO or via feeding tube Quality-of-Life Assessment: Ancillary studies Questionnaire Administration: Ancillary studies
| Group | Source count |
|---|---|
| Celecoxib Arm | 4 |
| Placebo Arm | 7 |
Reported measurements
No Adjuvant Radiation Therapy
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Celecoxib Arm | 2 | Not reported | Not reported | Not reported | Not reported |
| Placebo Arm | 1 | Not reported | Not reported | Not reported | Not reported |
No days of missed adjuvant radiation therapy
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Celecoxib Arm | 2 | Not reported | Not reported | Not reported | Not reported |
| Placebo Arm | 5 | Not reported | Not reported | Not reported | Not reported |
More than 0 days of adjuvant radiation therapy
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Celecoxib Arm | 0 | Not reported | Not reported | Not reported | Not reported |
| Placebo Arm | 1 | Not reported | Not reported | Not reported | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- value
- 2
- group Id
- OG001
- value
- 1
- title
- No Adjuvant Radiation Therapy
- categories
- measurements
- group Id
- OG000
- value
- 2
- group Id
- OG001
- value
- 5
- title
- No days of missed adjuvant radiation therapy
- categories
- measurements
- group Id
- OG000
- value
- 0
- group Id
- OG001
- value
- 1
- title
- More than 0 days of adjuvant radiation therapy
- denoms
- counts
- group Id
- OG000
- value
- 4
- group Id
- OG001
- value
- 7
- units
- Participants
- description
- This outcome will report the number of participants who missed treatment days during adjuvant radiation, who did not miss any treatment days during adjuvant radiation, and the number of participants who did not start adjuvant radiation therapy.
- groups
- description
- Patients received celecoxib PO or via feeding tube BID starting 1 to 7 days prior to surgery and continued until the completion of radiation therapy (up to 6 months in total) in the absence of disease progression or unacceptable toxicity. Celecoxib: Given PO or via feeding tube Quality-of-Life Assessment: Ancillary studies Questionnaire Administration: Ancillary studies
- id
- OG000
- title
- Celecoxib Arm
- description
- Patients received placebo PO or via feeding tube BID starting 1 to 7 days prior to surgery and continued until the completion of radiation therapy (up to 6 months in total) in the absence of disease progression or unacceptable toxicity. Placebo: Given PO or via feeding tube Quality-of-Life Assessment: Ancillary studies Questionnaire Administration: Ancillary studies
- id
- OG001
- title
- Placebo Arm
- param Type
- COUNT_OF_PARTICIPANTS
- population Description
- One participant on the Celecoxib Arm was not evaluable for this outcome measure.
- reporting Status
- POSTED
- time Frame
- up to 140 days
- title
- Assessment of the Average Number of Treatment Days Missed During Adjuvant Radiation for Patients on Celecoxib Compared to Placebo.
- type
- SECONDARY
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice